SCHEMBL1710089

SCHEMBL1710089

CCCCOCCOc1ccccc1C

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 2/20 0.53
CYP1A2 P05177 1/20 0.53
CYP2C9 P11712 1/20 0.53
TDP1 Q9NUW8 3/20 0.49
DRD2 P14416 2/20 0.49
DRD4 P21917 2/20 0.49
DRD3 P35462 1/20 0.49
CYP2D6 P10635 1/20 0.49
ALDH1A1 P00352 4/20 0.48
KDM4E B2RXH2 3/20 0.48
L3MBTL1 Q9Y468 2/20 0.48
PTGES O14684 1/20 0.46
ALOX5 P09917 1/20 0.46
PPARG P37231 1/20 0.46
PPARA Q07869 1/20 0.46
RARB P10826 1/20 0.46
MAPT P10636 3/20 0.45
SMN1; SMN2 Q16637 3/20 0.45
LMNA P02545 2/20 0.45
TSHR P16473 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1071252 0.91 CYP2C19 (0.62) CYP2C19CYP1A2CYP2C9TDP1DRD2
SCHEMBL23267782 0.89 TDP1 (0.49) CYP2C19CYP1A2CYP2C9TDP1DRD2
SCHEMBL19456536 0.89 ALDH1A1 (0.50) CYP2C19TDP1DRD2DRD4DRD3
SCHEMBL23267297 0.89 ALDH1A1 (0.50) CYP2C19TDP1DRD2DRD4DRD3
SCHEMBL16667608 0.89 CYP1A2 (0.60) CYP2C19CYP1A2CYP2C9TDP1CYP2D6
SCHEMBL16676018 0.89 CYP1A2 (0.60) CYP2C19CYP1A2CYP2C9TDP1CYP2D6
SCHEMBL16669243 0.89 CYP1A2 (0.60) CYP2C19CYP1A2CYP2C9TDP1CYP2D6
SCHEMBL18312558 0.89 ALDH1A1 (0.55) CYP2C19TDP1DRD2DRD4DRD3
SCHEMBL10491992 0.89 ALDH1A1 (0.55) CYP2C19TDP1DRD2DRD4DRD3
SCHEMBL1710099 0.85 TDP1 (0.51) CYP2C19TDP1DRD2DRD4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11693310-B2 Blue curable resin composition, blue color filter, and display device including same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2023-07-04 US disclosed
US-11693310-B2 Blue curable resin composition, blue color filter, and display device including same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2023-07-04 US disclosed
US-20230043562-A1 COLORED RESIN COMPOSITION SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2023-02-09 US disclosed
US-20200371435-A1 BLUE CURABLE RESIN COMPOSITION, BLUE COLOR FILTER, AND DISPLAY DEVICE INCLUDING SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2020-11-26 US disclosed
US-9051397-B2 Oxime ester BASF SE (DE) 2015-06-09 US disclosed
US-9051397-B2 Oxime ester BASF SE (DE) 2015-06-09 US disclosed
EP-2625166-B1 OXIME ESTER DERIVATIVES OF BENZOCARBAZOLE COMPOUNDS AND THEIR USE AS PHOTOINITIATORS IN PHOTOPOLYMERIZABLE COMPOSITIONS BASF SE (DE) 2014-09-24 EP disclosed
US-20130188270-A1 OXIME ESTER BASF SE (DE) 2013-07-25 US disclosed
US-20130188270-A1 OXIME ESTER BASF SE (DE) 2013-07-25 US disclosed
WO-2012045736-A1 OXIME ESTER DERIVATIVES OF BENZOCARBAZOLE COMPOUNDS AND THEIR USE AS PHOTOINITIATORS IN PHOTOPOLYMERIZABLE COMPOSITIONS BASF SE (DE) 2012-04-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130188270-A1 OXIME ESTER CBR3, CBR1, COX15 CYP2C19 13/4885CYP1A2 103/4885CYP2C9 56/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.